Next Financial Group’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BLRX
AIM
PHP
PAM
JF
GWM
Next Financial Group's BLRX Position: Q4 2021 in Review
Next Financial Group held its BioLineRX (BLRX) position steady in Q4 2021 at 68 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.
Next Financial Group first reported a position in BLRX in Q2 2014 and has held it in 30 quarters since. The position peaked at $99K in Q2 2015. 30 funds tracked by Wall St. Rank hold BLRX as of Q4 2021.
- Next Financial Group held 68 shares of BioLineRX worth $6K as of Q4 2021.
- Next Financial Group left its BioLineRX share count unchanged in Q4 2021.
- BioLineRX made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2353 holding.
- Next Financial Group first reported a position in BioLineRX in Q2 2014 and has held it in 30 quarters since.
- Next Financial Group's BioLineRX position peaked at $99K in Q2 2015.
- 30 funds tracked by Wall St. Rank held BioLineRX as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.